Author: Dr Peggy Chen MB ChB, Dermatology Registrar, Waikato Hospital, Hamilton, New Zealand, 2013.
Prurigo pigmentosa is a rare inflammatory skin condition of unknown cause. It is characterized by a recurrent itchy rash with netlike hyperpigmentation. It responds well to tetracycline, and has an excellent prognosis.
Prurigo pigmentosa is also known as Nagashima disease.
The exact cause of prurigo pigmentosa is unknown but several mechanisms have been proposed, including friction with clothes or a contact allergy to trichlorphenol, chromium in acupuncture needles, chrome in detergent, and nickel.
It has been associated in some patients with ketotic states associated with diabetes, fasting and post-bariatric surgery
Prurigo pigmentosa has been described in people of all ages, gender and ethnicities. However, it is more common amongst Asians, particularly young women. Women are affected twice as commonly as men.
In some patients, prurigo pigmentosa has been associated with systemic diseases such as Sjogren syndrome, and eating disorders such as anorexia nervosa. It has also been described in people with atopy, as well as in pregnancy.
Clinical features of prurigo pigmentosa include:
There is a distinct histopathology in prurigo pigmentosa.
Dapsone and tetracycline antibiotics are effective in treating prurigo pigmentosa during the inflammatory phase of the disease. These treatments are thought to work by interfering with the movement and function of neutrophils. Recently macrolide antibiotics such as erythromycin have also been demonstrated to be helpful.
To date there are no effective treatments for the hyperpigmentation that develops in the later stages of the disease. It eventually fades.
See the DermNet NZ bookstore
© 2018 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.